🎥 @juanosoriomd.bsky.social discusses a Phase I study on 2141-V11, an anti-CD40 antibody designed to enhance FcγRIIB binding, aiming to improve tumor response & reduce toxicity:
➡️ https://buff.ly/3BCEtJL ⬅️
@sitcancer.bsky.social #SITC24 #Immunotherapy
Maurer highlighted Myeloid Therapeutics' innovative work reprogramming myeloid cells for #immunotherapy. These cells, which naturally fight pathogens and infiltrate the TME, are engineered to target and destroy tumor cells while activating NK and T cells. acir.org/weekly-dige... #SITC24
Our team just wrapped up #SITC24! We're thrilled to share insights from 16 groundbreaking talks on the latest in #immunotherapy. 🧬✨ Stay ahead in the field—click here to catch all the updates! bit.ly/4fZzRMh #SITC2024
It was an honor to speak alongside Dr. Ana Anderson at the #SITC24 Primer this year and tag-team an introduction to the Cancer Immunity Cycle. If you (or your trainees) want an intro to immunotherapy concepts before doing a deep dive at the Annual Meeting, join us a day early next year!
Another great year at #SITC24! Thank you to the #SITC Early Career Scientist Committee for another amazing year of programming. Excellent conversations at the Meet the Expert Lunch, Grant Writing Workshop, Speed Mentoring & the Networking Event. #SITC25 can't come fast enough!
✨Excited for #SITC24!
Catch the poster presentations by @ervin_ascic titled "In vivo dendritic cell reprogramming for cancer immunotherapy"
Information about the sessions below 👇
📌Join us at the @sitcancer conference at the George R. Brown Convention Center, Houston, Nov 6-10.
Traveling to Houston later this week fory very first #SITC24 annual meeting. If you're also going and want to meet up, definitely let me know!
Another @sitcancer meeting is complete! So much science and so many reunions packed into so few days. Great @sitcancerECS programming, an excellent #Checkpoints show, some comedy and a little bit of magic! #SITC23 was a huge success. Already excited for #SITC24!
